Start for free
Start for free
Tybourne Capital Management logo

Tybourne Capital Management

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

Tybourne is a global investment firm with a fundamental approach to equity investing, both public and private

Investor Profile

Tybourne Capital Management has made 24 investments, with 2 in the past 12 months and 21% as lead.

Stage Focus

  • Series C (33%)
  • Series B (29%)
  • Series D (13%)
  • Series A (8%)
  • Series Unknown (4%)
  • Post Ipo Debt (4%)
  • Series E (4%)
  • Post Ipo Equity (4%)

Country Focus

  • United States (33%)
  • Japan (17%)
  • India (17%)
  • China (13%)
  • South Korea (4%)
  • United Kingdom (4%)
  • Switzerland (4%)
  • Vietnam (4%)
  • Indonesia (4%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Payments
  • Health Care
  • E-commerce
  • Software
  • Finance
  • Fintech
  • Biopharma
  • Information Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tybourne Capital Management frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 5
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 3
Farallon Capital Management
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 3
SBI Investment
SBI Investment
Asia, Chiba, Japan, Minato
Co-Investments: 2
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
Temasek Holdings
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Marshall Wace
Marshall Wace
Europe, England, United Kingdom, London
Co-Investments: 3
Viking Global Investors
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 3
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 4
Alpha Wave Global
Alpha Wave Global
North America, Florida, United States, Miami
Co-Investments: 3

Which angels does Tybourne Capital Management often collaborate with?

MM
Masayuki Mochida
Asia, Japan
Shared Deals: 1
BT
Belinda Termeer
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
RT
Ratan Tata
North America, Texas, United States, Houston
Shared Deals: 1

What are some of recent deals done by Tybourne Capital Management?

Forte Biosciences

Sherman Oaks, California, United States

Forte Biosciences is a biotechnology company that focuses on dermatology.

BiotechnologyHealth CareLife SciencePharmaceutical
Post Ipo EquityNov 20, 2024
Amount Raised: $53,000,000
SkyCell

Zürich, Zurich, Switzerland

SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.

LogisticsPharmaceuticalSupply Chain ManagementTransportation
Series DJun 25, 2024
Amount Raised: $59,000,000
Forte Biosciences

Sherman Oaks, California, United States

Forte Biosciences is a biotechnology company that focuses on dermatology.

BiotechnologyHealth CareLife SciencePharmaceutical
Post Ipo DebtAug 1, 2023
Amount Raised: $25,000,000
Asuene

Tokyo, Tokyo, Japan

Asuene provides renewable power retail services for local production and consumption.

EnergyLocalRenewable Energy
Series BSep 14, 2022
Amount Raised: $17,491,814
ACELYRIN

Los Angeles, California, United States

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

BiopharmaBiotechnologyHealth Care
Series CSep 13, 2022
Amount Raised: $300,000,000
Kopi Kenangan

Jakarta, Jakarta Raya, Indonesia

Kopi Kenangan is Indonesia’s fastest-growing coffee chain, leveraging on a tech-based 'grab & go' strategy.

CoffeeFood and Beverage
Series CDec 27, 2021
Amount Raised: $96,000,000
Lunit

Seoul, Seoul-t'ukpyolsi, South Korea

Lunit is a medical technology company that specializes in developing and providing AI-powered medical imaging solutions.

Artificial Intelligence (AI)Computer VisionHealth DiagnosticsImage RecognitionMachine LearningMedical DeviceSoftware
Series UnknownNov 29, 2021
Amount Raised: $61,000,000
ACELYRIN

Los Angeles, California, United States

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

BiopharmaBiotechnologyHealth Care
Series BNov 16, 2021
Amount Raised: $250,000,000
CADDi

Kuramae, Tokyo, Japan

CADDi is an online ordering platform that tracks industrial products for the manufacturing business.

Information ServicesInformation TechnologyManufacturingSupply Chain Management
Series BAug 23, 2021
Amount Raised: $73,213,985
Zentera Therapeutics

Shanghai, Shanghai, China

Zentera Therapeutics is a biopharmaceutical company.

BiotechnologyPharmaceutical
Series BAug 4, 2021
Amount Raised: $75,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator